Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis

Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998

Péter Ferenci, Alan H. Lockwood, Kevin D. Mullen et al. · Hepatology · 2002 · 2K citations · Full text

Medicine, Neurology, Gastroenterology +7

Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites

Pere Ginès, Vicente Arroyo, Enrique Quintero et al. · Gastroenterology · 1987 · 471 citations · Full text

Pharmacy, Pharmacotherapy, Drug Repurposing +5

Some Simple Robust Methods for the Analysis of Recurrent Events

Jerald F. Lawless, Claude Nadeau · Technometrics · 1995 · 454 citations

Engineering, Biostatistics, Statistics +14

Natural History of Patients Hospitalized for Management of Cirrhotic Ascites

Ramón Planas, Silvia Montoliu, Belén Ballesté et al. · Clinical Gastroenterology and Hepatology · 2006 · 398 citations

Medicine, Clinical Sciences, Internal Medicine +8

A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: A multicenter, randomized, placebo-controlled trial

Florence Wong, Andrés T. Blei, Laurence M. Blendis et al. · Hepatology · 2003 · 290 citations

Medicine, Pharmacology, Pharmacotherapy +17